Namrata Saroj

Chief Business Officer, Ocular Therapeutix, Inc

Bought, 12 months

$0.0M

Sold, 12 months

$0.3M

Companies

Latest trade

Nov 5, 2025

Companies

Ocular Therapeutix, IncChief Business Officer −$0.3M

Trades

OCUL Sold 25,865 shares at $10.74 · planned $0.3M Nov 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.